Analgesics in Singapore
Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the pandemic. In 2023, however, with the threat of COVID-19 largely mitigated, the growth rate of systemic analgesics is set to normalise, and topical analgesics/anaesthetic will be the category that stands to see a higher increase in current value sales, espe...
Euromonitor International's Analgesics in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in Singapore
- Euromonitor International
- October 2023
- List Of Contents And Tables
- ANALGESICS IN SINGAPORE
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Topical analgesics/anaesthetic is the top-performing category, while growth for systemic analgesics eases
- Increased travel enables rebound for herbal/traditional topical analgesics/anaesthetic
- GSK Consumer Healthcare continues to lead analgesics
- PROSPECTS AND OPPORTUNITIES
- Evolving demographics will enable stable growth in topical analgesics/anaesthetic
- Systemic analgesics likely to continue to see a slowdown, due to lower threat from COVID-19
- Concerns surrounding transparency and clear brand communication for herbal/ traditional products may hamper growth
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2018-2023
- Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
- Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
- Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
- Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
- CONSUMER HEALTH IN SINGAPORE
- EXECUTIVE SUMMARY
- Consumer health in 2023: The big picture
- 2023 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
- Table 8 Life Expectancy at Birth 2018-2023
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2018-2023
- Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
- Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
- Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
- Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
- Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook